[LGND] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -102.16%
YoY- -119.71%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 33,161 27,003 24,808 24,987 43,484 59,590 45,663 -19.19%
PBT -30,415 -8,175 -19,871 -18,028 842,713 -56,789 79,226 -
Tax -6,284 -810 -4,620 -3,609 176,376 -14,307 11,864 -
NP -24,131 -7,365 -15,251 -14,419 666,337 -42,482 67,362 -
Tax Rate - - - - -20.93% - -14.97% -
Total Cost 57,292 34,368 40,059 39,406 -622,853 102,072 -21,699 -
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -72.77 -27.27 -61.48 -57.71 1,532.37 -71.29 147.52 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -1.46 -0.43 -0.81 -0.74 32.59 -2.02 3.19 -
EPS Diluted -1.46 -0.43 -0.81 -0.74 31.32 -2.02 2.80 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.